Document Type : Letter to Editor
Authors
1
Professor, Nutrition and Metabolic Diseases Research Center, and Paramedical School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2
Assistant Professor, Department of Virology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3
Professor, Endocrine and Metabolism Research Center of Isfahan. Isfahan University of Medical Sciences, Isfahan, Iran
4
Assistant Professor, Endocrine and Metabolism Research Center of Isfahan. Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Viral infections, especially adenovirus 36 (Ad-36) infection, are considered an important factor in the development of obesity. The effects of Ad-36 infection are contradictory. On the one hand, Ad-36 infection leads to weight gain and fat accumulation, increased inflammation, and entry of macrophages into fat cells, causing obesity. On the other hand, it leads to reduced insulin resistance, improved lipid profile, and glycemic control. These effects may partly explain the variability in individual responses to antidiabetic drugs such as metformin and pioglitazone. Moreover, Ad-36 infection may potentially influence the development of new antidiabetic drugs. Further studies in this field are necessary.
Highlights
Majid Karandish: Google Scholar, PubMed
Ali Teimoori: Google Scholar
Mansour Siavash: Google Scholar
Fatemeh Shirani: Google Scholar, PubMed
Keywords
Subjects